Overview

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Status:
Completed
Trial end date:
2016-11-14
Target enrollment:
Participant gender:
Summary
Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Collaborator:
Dow Pharmaceutical Sciences